Skip to main content
OpenTrials
Completed

NCT Number: NCT01872156

Effectiveness of an Intervention in Primary Care to Promote Smoking Cessation in Pregnant Women

The purpose of this study is to evaluate the effectiveness of the behavior treatment accompanied by self-help materials in Primary health care, across the intervention of the midwifes in the pregnancy follow-up visits.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Gerencia de Atención Primaria

Madrid, 28850, Spain

About this study

Aim: To evaluate the efficiency of an intervention in smoking based on a clinical practice guideline on the part of the primary care professionals on tobacco abstinence at the conclusion of the pregnancy self referred and validated with cooximetry.

Secondary objectives:

  • To evaluate the effectiveness of an intervention in smoking based on a clinical practice guideline on the part of the primary care professionals on the tobacco abstinence 6 months after the childbirth.
  • The effectiveness of the intervention values on the weight of the newborn child, the number of childbirths pre-term and the perinatal mortality.
  • To study the effectiveness of the intervention in smoking on the maintenance of the breast-feeding to 3 and 6 months.

Method:

Design: cluster randomized controlled trial. Setting: study in Health Centers Primary Care of Area of Madrid Health Service.

Sample size adjusted for design effect: number of smoking women in every branch would be of 350.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • pregnant at 20 weeks or less of gestation
  • attending her first prenatal visit with any of the participating prenatal care teams (this first prenatal visit takes place usually around 6-12 weeks of pregnancy)
  • defining herself as a current cigarette smoker or recent ex-smoker (see below for a definition of these terms)
  • being able to meet the requisites of the trial:
  • being available for the next 15 months
  • defining herself as fluent in reading and speaking Spanish to understand the study procedures and to comply with them
  • meeting no exclusion criterion; and
  • willing and able to give informed consent for participation in the study

Exclusion criteria

  • communication barrier;
  • active addictions to other psychoactive substances
  • involved in any other formal smoking cessation program or in another trial during the study period; or
  • does not consent to participate in the study

Treatment and study plan

Intervention GESTABAC

Other

Intervention based on the "Clinician's Guide to helping Pregnant Women Quit Smoking" on the rates of abstinence of the patients in whom it has been controlled in this period of time, at the end of the pregnancy and after the childbirth.

Control Group

Other

The group control will act according to usual management.

Primary outcomes

  1. Rate of abstinence of tobacco

    Time frame: 6 months

    Rate of abstinence of tobacco to 20-28 weeks of childbearing , to 36-38 weeks and to 6 postpartum (post-childbearing) months. The abstinence will be validated for cooximetry.

Sponsors and collaborators

Lead sponsor

Gerencia de Atención Primaria, Madrid

Other Gov

Registry information

Official study title

Effectiveness of an Intervention in Primary Care to Promote Smoking Cessation in Pregnant Women: Cluster Randomized Controlled Trial.

Acronym: GESTABAC

Important dates

Study start
2013
Primary completion
2014
Study completion
2017
First posted
Jun 7, 2013
Registry last updated
Aug 14, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.